KLK3 and prostate cancer: Among all 53 individuals detected with elevated PSA levels in this study, 31 with PSA 4.19–23.52 ng/mL did not have prostate cancer after undergoing TRUS biopsy, reflecting the reliability issue of PSA being a widely used diagnostic tool with a cut off value at 4 ng/mL.